Year: 2025
Type: article
Abstract: to immune therapies and provide a basis for the development of novel therapeutic concepts.
DOI: 10.1111/jdv.70019
Authors: Eftychia Chatziioannou, Martin Röcken
Institution: University of Tübingen
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $5,450
Funder: AstraZeneca
OpenAlex ID: W4415543334